Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03332537 · ClinicalTrials.gov registry record · NA

Precision Pain Self-Management in Young Adults With Irritable Bowel Syndrome

A NA study of Irritable Bowel Syndrome, sponsored by University of Connecticut.

Completed
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT03332537 is a NA study of Irritable Bowel Syndrome that has completed, run by University of Connecticut. The registered enrollment target is 80 participants, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (44% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03332537, a NA study of Irritable Bowel Syndrome, has completed, sponsored by University of Connecticut.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

This pilot project will provide foundational information about the contextual factors of irritable bowel syndrome (IBS) related pain (pain catastrophizing, perceived stress, reactivity pain sensitivity, genetic and microbiome) on pain self-management (SM) process and outcomes. In addition, the investigators will gain insight on the potential impact of the personalized IBS-pain SM approach on pain SM behaviors and health outcomes.

Conditions Studied

Interventions

  • BEHAVIORAL Personalized IBS Pain SM

Study Locations (2)

Connecticut

  • UConn Health Center - Farmington
  • University of Connecticut - Storrs

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2016-10-01
Est. Completion 2018-12-31
Phase NA

Sponsor

University of Connecticut

107 total trials

What the Registry Record Tells You About NCT03332537

The ClinicalTrials.gov registry entry for NCT03332537 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 143-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (44% lower). The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Personalized IBS Pain SM is the first listed.

NCT03332537 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT03332537 about?

NCT03332537 is a clinical study titled "Precision Pain Self-Management in Young Adults With Irritable Bowel Syndrome". This pilot project will provide foundational information about the contextual factors of irritable bowel syndrome (IBS) related pain (pain catastrophizing, perceived stress, reactivity pain sensitivity, genetic and microbiome) on pain self-management (SM) process and outcomes. In addition, the inves...

What is the current status of trial NCT03332537?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2016-10-01. Estimated completion is 2018-12-31.

What conditions does trial NCT03332537 study?

This clinical trial studies the following conditions: Irritable Bowel Syndrome.

What interventions are being tested in trial NCT03332537?

The interventions under investigation include: Personalized IBS Pain SM (BEHAVIORAL).

Who is sponsoring clinical trial NCT03332537?

This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03332537 being conducted?

This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Irritable Bowel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.